Company in the News: Zhongji Innolight
The optical module maker that supplies the world’s tech giants with crucial data center hardware has come under U.S. scrutiny.
Articles
The Long Arm of the Chinese Academy of Sciences
Far more than just a research institution, CAS is a key investor behind many of China’s leading technology companies.
Getting Strict on Chinese Military Companies
The Department of Defense has made some surprising new inclusions on its latest list of companies that support China’s armed forces.
How the PLA Has Tried to Get Around Chip Export Controls
Procurement tenders shows how military agencies attempted to purchase Nvidia hardware through a network of commercial partners.
Company In The News: JinkoSolar
One of China’s biggest solar firms sells its Florida subsidiary as Chinese clean-tech investment to the United States struggles.
Assessing the Summit
There were no major breakthroughs — or disasters — at Donald Trump’s much hyped summit with Xi Jinping in Beijing. Does that make it a success? The Wire China polled four Chinese scholars, three American experts and the relative of a Chinese political prisoner.
The Chinese Companies That Made the Trump-Xi Dinner Cut
The list of Chinese firms represented at last week’s state dinner reveals much about Beijing’s priorities for the meeting.
Beijing Flexes Its Sanctions Muscle
China’s decision to ignore recent U.S. sanctions on its oil industry shows its willingness to use a legal toolkit compiled since 2020.
Company in the News: Rokid
China’s biggest smart glasses vendor, Rokid, gets IPO-ready.
China’s Eyes in the Sky Make Their Mark
The advancements of China’s satellite imaging industry present a new risk for military secrecy, as the Iran conflict illustrates.
How China’s EV Companies are Winning the War
All of China's top electric vehicle makers saw exports charge ahead in March, although some of their costs are rising too.
How Big Pharma’s China Trials Are Escaping Scrutiny
U.S. supply chains with connections to Xinjiang and the Chinese military are heavily regulated — just not for pharmaceuticals.